Wells Fargo
PYXS icon

Wells Fargo’s Pyxis Oncology PYXS Stock Holding History

Wells Fargo’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$858 Hold
285
– – ﹤0.01% 6469
2026
Q1 		$416 Sell
285
-2,000
-88% -$3.01K ﹤0.01% 6413
2025
Q4 		$2.63K Buy
2,285
+2,000
+702% +$7.05K ﹤0.01% 6193
2025
Q3 		$633 Sell
285
-414
-59% -$596 ﹤0.01% 6285
2025
Q2 		$769 Sell
699
-29,191
-98% -$32.9K ﹤0.01% 6336
2025
Q1 		$29.3K Buy
29,890
+941
+3% +$1.25K ﹤0.01% 5579
2024
Q4 		$45.2K Buy
28,949
+4,724
+20% +$13.6K ﹤0.01% 5518
2024
Q3 		$88.9K Buy
24,225
+2,183
+10% +$7.64K ﹤0.01% 5085
2024
Q2 		$73K Buy
22,042
+21,208
+2,543% +$89.2K ﹤0.01% 5121
2024
Q1 		$3.55K Sell
834
-1,697
-67% -$7.14K ﹤0.01% 5946
2023
Q4 		$4.56K Buy
2,531
+23
+0.9% +$39 ﹤0.01% 5972
2023
Q3 		$4.99K Buy
2,508
+38
+2% +$88 ﹤0.01% 5956
2023
Q2 		$6.32K Buy
2,470
+307
+14% +$974 ﹤0.01% 6035
2023
Q1 		$8.67K Buy
2,163
+2,003
+1,252% +$4K ﹤0.01% 5906
2022
Q4 		$214 Buy
160
+14
+10% +$21 ﹤0.01% 6601
2022
Q3 		$0 Buy
146
+76
+109% +$199 ﹤0.01% 7212
2022
Q2 		$0 Sell
70
-5,245
-99% -$14K ﹤0.01% 7334
2022
Q1 		$21K Sell
5,315
-6,099
-53% -$44.6K ﹤0.01% 5993
2021
Q4 		$125K Buy
+11,414
New +$131K ﹤0.01% 5517

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo's PYXS Position: Q2 2026 in Review

Wells Fargo held its Pyxis Oncology (PYXS) position steady in Q2 2026 at 285 shares worth $858. The position accounts for ﹤0.01% of the portfolio, ranked #6469.

Wells Fargo first reported a position in PYXS in Q4 2021 and has held it in 19 quarters since. The position peaked at $125K in Q4 2021. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Wells Fargo held 285 shares of Pyxis Oncology worth $858 as of Q2 2026.
  • Wells Fargo left its Pyxis Oncology share count unchanged in Q2 2026.
  • Pyxis Oncology made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6469 holding.
  • Wells Fargo first reported a position in Pyxis Oncology in Q4 2021 and has held it in 19 quarters since.
  • Wells Fargo's Pyxis Oncology position peaked at $125K in Q4 2021.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.